Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXaar Regulatory News (XAR)

Share Price Information for Xaar (XAR)

Share Price is delayed by 15 minutes
Get Live Data
132.00    -3.50 (-2.58%)
Bid:
133.00
Ask:
139.50
Spread: 6.50 (4.887%)
Market Cap: £103.58m
XAR Live PriceLast checked at - London Stock Exchange

Intraday Xaar Share Chart

Systems integration partner

13 May 2005 07:01

Xaar PLC13 May 2005 FOR IMMEDIATE RELEASE 13 May 2005 Xaar plc IMPIKA APPOINTED AS SYSTEMS INTEGRATION PARTNER Xaar plc ("Xaar"), the inkjet printing technology group headquartered inCambridge, and IMPIKA SA ("IMPIKA") of Aubagne, France are pleased to announce ajoint agreement for the provision of integration services for Xaar printheadsand other products. Under the agreement both parties will co-operate to provide complete turnkeysolutions for clients wishing to use Xaar technology for their productionprocesses, to open up new applications and create bespoke solutions. IMPIKA haslong experience with inkjet, including its application to the printing ofplastic and smart cards, packaging, labelling as well as special applicationsfor printing on CDs, glass and metal. Impika is also developing solutions basedon its material jetting technology for microelectronics and biomedicalapplications. Nigel Berry, Deputy CEO of Xaar commented: "I am very pleased to announce thisrelationship with IMPIKA. We previously stated our intention to partner with asmall number of high quality integrators which can offer existing and potentialusers of our technology a complete package of integration skills and bespokeequipment. We have known the team at IMPIKA for some time now and have beenimpressed by their standards and innovation. I look forward to working withthem on future projects." Paul Morgavi, IMPIKA'S CEO said: "Xaar is a great partner for us and we arealready forming strong links with their technical and marketing teams. There isa clear synergy between Xaar and Impika with both parties introducing newmarkets into the joint relationship. Last year we introduced our C9000 productbased on Xaar's Leopard printhead and we are working on various projects foradapting our IPS print engine to the next generation of Xaar printheads, likethe Omnidot and HSS. Full commercial release of these products is anticipatedlater this year or early next year." About Xaar Xaar plc is a market-leading inkjet technology company. It targets the world'sindustrial, commercial and office printing markets. The industrial andcommercial printing markets are targeted by Xaar's own range of inkjet productsin conjunction with partners and other key players in those markets; the officeprinting market is approached through Xaar's strong list of licensees.Additional information about Xaar is available at www.xaar.co.uk. About IMPIKA: Created in March 2003 as a spin-out from Gemplus, IMPIKA is headquartered atAubagne in the south of France. IMPIKA offers high-performance industrialprinting and material jetting solutions using inkjet technology; it currentlyhas 37 employees. IMPIKA designs, develops, implements and markets hardware and softwaresolutions, as well as the required engineering as regards ink and materialjetting, for industrial applications including digital printing,microelectronics and biotechnologies. Additional information about IMPIKA isavailable at www.impika.com. Contacts Xaar plc: 01223-423663Ian Dinwoodie, Chief Executive www.xaar.co.ukNigel Berry, Group Finance Director & Deputy Chief Executive IMPIKA: +33 (0)4 42 62 43 00Paul Morgavi, CEO www.impika.com Bankside Consultants:Steve Liebmann 020-7444-4163 /07802-888159 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
30th Nov 20123:32 pmRNSTotal Voting Rights
22nd Oct 20127:00 amRNSDirector/PDMR Shareholding
18th Oct 20127:00 amRNSIMS and Corporate Open Day
1st Oct 20122:58 pmRNSTotal Voting Rights
26th Sep 20127:00 amRNSTR-1
24th Sep 20127:00 amRNSXAAR'S PARTNERS LAUNCH XAAR 1001 GS12 PRINTERS
3rd Sep 20123:19 pmRNSTotal Voting Rights
16th Aug 20127:00 amRNSInterim Results
1st Aug 201210:02 amRNSTotal Voting Rights
24th Jul 20127:00 amRNSXaar Joins Make It In Great Britain Exhibition
19th Jul 20127:00 amRNSTrading Statement
18th Jul 20129:34 amRNSHolding(s) in Company
13th Jul 20124:41 pmRNSHolding(s) in Company
3rd Jul 20124:23 pmRNSAdditional Listing
29th Jun 20126:20 pmRNSBlocklisting Interim Review
28th Jun 20127:00 amRNSPositive Response To New P3 Product Launch
27th Jun 201210:04 amRNSHolding(s) in Company
26th Jun 201210:11 amRNSDirector/PDMR Shareholding
12th Jun 20125:39 pmRNSHolding(s) in Company
11th Jun 20124:31 pmRNSDirector/PDMR Shareholding
7th Jun 201210:10 amRNSHolding(s) in Company
1st Jun 20129:24 amRNSDirector Declaration
31st May 20124:54 pmRNSTotal Voting Rights
22nd May 20124:54 pmRNSResult of AGM
17th May 20121:21 pmRNSHolding(s) in Company
4th May 20127:00 amRNSNotice of AGM
3rd May 20124:35 pmRNSHolding(s) in Company
2nd May 20123:12 pmRNSGrant of Options
1st May 20129:38 amRNSTotal Voting Rights
25th Apr 20125:21 pmRNSHolding(s) in Company
25th Apr 201211:26 amRNSDirector/ PDMR Shareholding
23rd Apr 20127:00 amRNSDirector/PDMR Shareholding
19th Apr 20127:00 amRNSAnnual Information Update
19th Apr 20127:00 amRNSInterim Management Statement
16th Apr 20126:13 pmRNSDirector/PDMR Shareholding - Replacement
13th Apr 20128:54 amRNSDirector/PDMR Shareholding
5th Apr 20123:25 pmRNSDirector/PDMR Shareholding
3rd Apr 20127:00 amRNSIssue of Options
30th Mar 20125:39 pmRNSTotal Voting Rights
19th Mar 20127:00 amRNSFinal Results
15th Mar 20127:00 amRNSHolding(s) in Company
9th Mar 20124:00 pmRNSHolding(s) in Company
1st Mar 20128:30 amRNSHolding(s) in Company
29th Feb 20128:48 amRNSHolding(s) in Company
28th Feb 20127:00 amRNSChange of 2011 Results Announcement Date
20th Feb 20125:33 pmRNSHolding(s) in Company
20th Feb 20125:24 pmRNSHolding(s) in Company
24th Jan 20126:05 pmRNSHolding(s) in Company
24th Jan 20127:00 amRNSChina Staff Changes
19th Jan 20127:00 amRNSTrading Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.